ARCH Venture Fund IX L.P. 13D and 13G filings for Karuna Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-09-20 4:58 pm Sale |
2022-08-12 | 13D | Karuna Therapeutics, Inc. KRTX |
ARCH Venture Fund IX L.P. | 0 0.000% |
-2,946,891 (Position Closed) |
Filing |
| 2021-04-22 7:22 pm Sale |
2021-04-13 | 13D | Karuna Therapeutics, Inc. KRTX |
ARCH Venture Fund IX L.P. | 2,946,891 10.000% |
-135,744 (-4.40%) |
Filing |
| 2021-01-19 1:25 pm Sale |
2021-01-08 | 13D | Karuna Therapeutics, Inc. KRTX |
ARCH Venture Fund IX L.P. | 3,082,635 11.500% |
-280,237 (-8.33%) |
Filing |